Desicorpinc
Louisville, US · Delaware corporation · 1 known investors
DesiCorp develops advanced packaging and stabilization solutions for biopharmaceutical and therapeutic products, extending shelf-life without refrigeration to improve access in rural, remote, and emergency care settings. The company uses specialized materials and two-chambered packaging designs to preserve sensitive compounds during transport and storage in austere environments.
Founders & leadership
BJ
Brett JanisCEO/CSO, Treasurer, and Co-founder
JK
Jonathan KopechekSecretary and Co-founder
MM
Michael MenzePresident and Co-founder
JK
Jonathan KopecheckExecutive
Board
RS
Robert SaundersBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$8.7M disclosed across 2 rounds · 2024–2026
▶$3.5MraisedJun 2026 · 12 investors · BiotechnologyRule 506(b)
▶$3.5MraisedJun 2026 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael MenzeExecutive Officer, Director
- Jonathan KopecheckExecutive Officer, Director
- Brett JanisExecutive Officer, Director
- Robert SaundersDirector
- Offering amount
- $6M
- Amount sold
- $3.5M
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.2MraisedJan 2026 · 15 investors · BiotechnologyRule 506(b)
▶$5.2MraisedJan 2026 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert SaundersDirector
- Michael MenzeExecutive Officer, Director
- Jonathan KopecheckExecutive Officer, Director
- Brett JanisExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $5.2M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapLabcorp10 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
IQVIA8 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Dialectic Therapeutics6 shared keywordsDialectic Therapeutics is a clinical-stage biotechnology company developing anti-cancer drugs using its Antiapoptotic Protein Targeted Degradation (APTaD) platform, which induces cancer cells to degrade proteins such as BCL-XL. Its lead candidate, DT2216, is in Phase 1/2 trials for fibrolamellar carcinoma and platinum-resistant ovarian cancer.
Companies competing with Desicorpinc for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Desicorpinc do?
- DesiCorp develops advanced packaging and stabilization solutions for biopharmaceutical and therapeutic products, extending shelf-life without refrigeration to improve access in rural, remote, and emergency care settings. The company uses specialized materials and two-chambered packaging designs to preserve sensitive compounds during transport and storage in austere environments.
- Who founded Desicorpinc?
- Desicorpinc was founded by Brett Janis, Jonathan Kopechek, Michael Menze.
- Who are Desicorpinc's investors?
- Desicorpinc's investors include Keyhorse Capital.
- How much funding has Desicorpinc raised?
- Desicorpinc has disclosed $8.7M raised across 2 rounds.
- Where is Desicorpinc headquartered?
- Desicorpinc is headquartered in Louisville, US.